NCT01238367 A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543 Status COMPLETED Phase PHASE1
NCT01237119 Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis Status COMPLETED Phase PHASE2
NCT01234649 Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM) Status COMPLETED Phase PHASE3
NCT01234545 Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors Status COMPLETED Phase N/A
NCT01232491 Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01230021 Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency Status COMPLETED Phase PHASE3
NCT01228669 Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B Status COMPLETED Phase PHASE1
NCT01226966 Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase N/A
NCT01223911 A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01220141 Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B Status COMPLETED Phase N/A
NCT01215435 Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone Status COMPLETED Phase PHASE4
NCT01212133 A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India Status COMPLETED Phase N/A
NCT01208506 First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01208012 Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01206101 Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation Status TERMINATED Phase PHASE2
NCT01205724 Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A Status COMPLETED Phase PHASE1